What are Pacific Biosciences of California's profit margins?

Pacific Biosciences of California (PACB) runs a 37.5% gross margin and a -83.3% operating margin, with a -80.3% net margin.

Where do Pacific Biosciences of California's ratios come from?

Every ratio is computed from Pacific Biosciences of California's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Pacific Biosciences of California PACB Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	37.5%+8.9pp	28.6%+3.2pp	25.4%+4.0pp	21.4%+5.2pp	16.2%-8.0pp
Operating margin	-83.3%+263pp	-346.2%+84.5pp	-430.6%+11.9pp	-442.6%+96.9pp	-539.4%-231pp
Net margin	-80.3%+261pp	-341.5%-14.1pp	-327.3%+11.4pp	-338.7%+94.6pp	-433.3%-231pp
EBITDA margin	-74.5%+32.7pp	-107.1%+72.3pp	-179.4%+9.5pp	-188.9%+86.3pp	-275.2%+6.0pp
Free cash flow margin	-72.6%-1.4pp	-71.2%+10.5pp	-81.7%+15.9pp	-97.6%+19.3pp	-116.9%+20.9pp
Returns
Return on equity	-273.6%-60.1pp	-213.5%-6.6pp	-206.9%-16.1pp	-190.8%-12.6pp	-178.3%-127pp
Return on assets	-15.6%+37.8pp	-53.4%-8.5pp	-44.9%+0.4pp	-45.3%+6.9pp	-52.2%-31.4pp
Return on invested capital	-304.3%—	——	-307.3%-19.8pp	-287.5%-50.0pp	-237.4%-146pp
Efficiency
Asset turnover	0.2×0.0×	0.2×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Inventory turnover	1.2×-0.2×	1.4×-0.1×	1.5×0.0×	1.6×-0.1×	1.7×0.0×
Liquidity
Current ratio	5.7×+0.5×	5.1×-1.1×	6.2×-0.7×	6.9×+0.2×	6.7×-0.8×
Quick ratio	4.4×+0.4×	4×-0.9×	4.9×-0.5×	5.5×0.0×	5.4×-0.8×
Cash ratio	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×0.0×
Leverage
Debt-to-equity	25.1×+14.4×	10.7×+9.1×	1.5×+0.7×	0.9×+0.3×	0.6×+0.5×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Interest coverage	-19.2×+60.5×	-79.6×+3.9×	-83.5×-12.8×	-70.7×+0.3×	-71×-35.6×
Per Share
Book value per share	$0.01-56.7%	$0.02-85.2%	$0.12-41.4%	$0.20-33.6%	$0.31-82.4%
Valuation
Market capitalization	$496.96M+30.4%	$564.57M+46.8%	$384.47M+6.8%	$360.1M+2.5%	$351.47M-34.7%
Enterprise value	$498.38M+33.5%	$556.35M+46.0%	$381.1M+7.0%	$356.25M+3.7%	$343.63M-32.1%
Price / sales	3.1×+0.6×	3.5×+1.0×	2.5×+0.2×	2.3×0.0×	2.3×-1.2×
Price / book	210×+206×	105.5×+94.9×	10.7×+4.8×	5.9×+2.0×	3.8×+2.8×
EV / sales	3.1×+0.7×	3.5×+1.0×	2.5×+0.2×	2.3×0.0×	2.3×-1.0×
Free cash flow yield	-23.4%+23.4pp	-20.2%+12.7pp	-32.8%+9.5pp	-42.3%+8.4pp	-50.7%-11.3pp
Earnings yield	-25.9%+147pp	-96.8%+34.8pp	-131.6%+15.2pp	-146.8%+41.0pp	-187.8%-130pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pacific Biosciences of California.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Pacific Biosciences of California's profit margins?: Pacific Biosciences of California (PACB) runs a 37.5% gross margin and a -83.3% operating margin, with a -80.3% net margin.
Where do Pacific Biosciences of California's ratios come from?: Every ratio is computed from Pacific Biosciences of California's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.